
Chinese General Practice ›› 2026, Vol. 29 ›› Issue (29): 4288-4294.DOI: 10.12114/j.issn.1007-9572.2024.0093
• Article • Previous Articles Next Articles
Received:2024-04-10
Revised:2024-07-10
Published:2026-10-15
Online:2026-09-02
Contact:
LI Weixia
通讯作者:
李卫霞
作者简介:作者贡献:
王晗负责课题实施与论文的撰写;陈剑华负责收集实验数据与整理并进行统计学分析;宋时莉、郝珍负责氢水制备及浓度检测;霍忠超、李沙负责论文审校与修订;李卫霞负责文章的构思与设计,并对文章负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0093
| 引物名称 | 基因编号 | 引物序列(5'-3') | 产物长度(bp) |
|---|---|---|---|
| NFE2L2 | NM_001313903.2 | 上游:AGTCCAGAAGCCAAACTGACAGAAG | 135 |
| 下游:GGAGAGGATGCTGCTGAAGGAATC | |||
| HMOX1 | NM_002133.3 | 上游:CTTCAAGCTGGTGATGGCCT | 97 |
| 下游:GTAGACAGGGGCGAAGACTG | |||
| ACTB | NM_001101.5 | 上游:GCACTCTTCCAGCCTTCCTTCC | 93 |
| 下游:GCGGATGTCCACGTCACACTTC |
Table 1 RT-qPCR primer sequence
| 引物名称 | 基因编号 | 引物序列(5'-3') | 产物长度(bp) |
|---|---|---|---|
| NFE2L2 | NM_001313903.2 | 上游:AGTCCAGAAGCCAAACTGACAGAAG | 135 |
| 下游:GGAGAGGATGCTGCTGAAGGAATC | |||
| HMOX1 | NM_002133.3 | 上游:CTTCAAGCTGGTGATGGCCT | 97 |
| 下游:GTAGACAGGGGCGAAGACTG | |||
| ACTB | NM_001101.5 | 上游:GCACTCTTCCAGCCTTCCTTCC | 93 |
| 下游:GCGGATGTCCACGTCACACTTC |
| 组别 | 细胞活力 |
|---|---|
| 对照组 | 100.00±0 |
| 顺铂1.25 mg/L亚组 | 88.55±1.48a |
| 顺铂2.50 mg/L亚组 | 68.59±2.68a |
| 顺铂5.00 mg/L亚组 | 38.95±2.15a |
| 顺铂10.00 mg/L亚组 | 23.27±1.52a |
| 顺铂20.00 mg/L亚组 | 10.65±1.98a |
| F值 | 1 168.00 |
| P值 | <0.001 |
Table 2 Cell activity comparison of WRL68 treated by different concentrations of cisplatin
| 组别 | 细胞活力 |
|---|---|
| 对照组 | 100.00±0 |
| 顺铂1.25 mg/L亚组 | 88.55±1.48a |
| 顺铂2.50 mg/L亚组 | 68.59±2.68a |
| 顺铂5.00 mg/L亚组 | 38.95±2.15a |
| 顺铂10.00 mg/L亚组 | 23.27±1.52a |
| 顺铂20.00 mg/L亚组 | 10.65±1.98a |
| F值 | 1 168.00 |
| P值 | <0.001 |
| 组别 | 细胞活力 |
|---|---|
| 对照组 | 100.00±0.04 |
| 顺铂组 | 59.93±2.89a |
| 低浓度氢水组 | 100.90±1.19 |
| 低浓度氢水+顺铂组 | 77.50±3.67ab |
| 中浓度氢水组 | 99.04±1.68 |
| 中浓度氢水+顺铂组 | 72.28±5.94ab |
| 高浓度氢水组 | 103.10±1.53 |
| 高浓度氢水+顺铂组 | 74.15±4.43ab |
| F值 | 80.590 |
| P值 | <0.001 |
Table 3 Comparison of survival rates of WRL68 cells in different groups after hydrogen water pretreatment
| 组别 | 细胞活力 |
|---|---|
| 对照组 | 100.00±0.04 |
| 顺铂组 | 59.93±2.89a |
| 低浓度氢水组 | 100.90±1.19 |
| 低浓度氢水+顺铂组 | 77.50±3.67ab |
| 中浓度氢水组 | 99.04±1.68 |
| 中浓度氢水+顺铂组 | 72.28±5.94ab |
| 高浓度氢水组 | 103.10±1.53 |
| 高浓度氢水+顺铂组 | 74.15±4.43ab |
| F值 | 80.590 |
| P值 | <0.001 |
| 组别 | 细胞凋亡率(%) | MMP | ROS |
|---|---|---|---|
| 对照组 | 2.49±0.38 | 1.00±0.05 | 1.00±0.15 |
| 顺铂组 | 32.90±1.97a | 0.35±0.01a | 6.52±0.99a |
| 氢水组 | 2.67±0.60b | 1.41±0.02ab | 1.05±0.18b |
| 氢水+顺铂组 | 23.15±1.19ab | 0.62±0.02ab | 4.00±0.40ab |
| F值 | 479.000 | 702.600 | 70.360 |
| P值 | <0.001 | <0.001 | <0.001 |
Table 4 Comparison of apoptosis rate and level of MMP and ROS in each group of WRL68 cells
| 组别 | 细胞凋亡率(%) | MMP | ROS |
|---|---|---|---|
| 对照组 | 2.49±0.38 | 1.00±0.05 | 1.00±0.15 |
| 顺铂组 | 32.90±1.97a | 0.35±0.01a | 6.52±0.99a |
| 氢水组 | 2.67±0.60b | 1.41±0.02ab | 1.05±0.18b |
| 氢水+顺铂组 | 23.15±1.19ab | 0.62±0.02ab | 4.00±0.40ab |
| F值 | 479.000 | 702.600 | 70.360 |
| P值 | <0.001 | <0.001 | <0.001 |
| 组别 | 蛋白 | mRNA | ||
|---|---|---|---|---|
| NFE2L2 | HMOX1 | NFE2L2 | HMOX1 | |
| 对照组 | 1.00±0.15 | 1.00±0.15 | 1.00±0.00 | 1.00±0.00 |
| 顺铂组 | 0.35±0.07a | 0.48±0.07a | 0.27±0.04a | 0.31±0.01a |
| 氢水组 | 2.54±0.09ab | 3.05±0.07ab | 1.56±0.33ab | 1.85±0.42ab |
| 氢水+顺铂组 | 0.89±0.14b | 2.19±0.11b | 0.90±0.19b | 1.29±0.27b |
| F值 | 194.600 | 386.900 | 22.670 | 19.720 |
| P值 | <0.001 | <0.001 | <0.001 | 0.001 |
Table 5 Comparison of relative levels of NFE2L2 and HMOX1 in each group of WRL68 cells
| 组别 | 蛋白 | mRNA | ||
|---|---|---|---|---|
| NFE2L2 | HMOX1 | NFE2L2 | HMOX1 | |
| 对照组 | 1.00±0.15 | 1.00±0.15 | 1.00±0.00 | 1.00±0.00 |
| 顺铂组 | 0.35±0.07a | 0.48±0.07a | 0.27±0.04a | 0.31±0.01a |
| 氢水组 | 2.54±0.09ab | 3.05±0.07ab | 1.56±0.33ab | 1.85±0.42ab |
| 氢水+顺铂组 | 0.89±0.14b | 2.19±0.11b | 0.90±0.19b | 1.29±0.27b |
| F值 | 194.600 | 386.900 | 22.670 | 19.720 |
| P值 | <0.001 | <0.001 | <0.001 | 0.001 |
| [1] |
中国医药生物技术协会药物性肝损伤防治技术专业委员会,中华医学会肝病学分会药物性肝病学组. 中国药物性肝损伤诊治指南(2023年版)[J].中华肝脏病杂志, 2023, 31(4): 355-384.
|
| [2] |
|
| [3] |
李容容,李盟,罗琼, 等. 国内外药物性肝损伤临床诊疗指南的比较分析[J]. 中华肝脏病杂志, 2023, 31(4): 433-439.
|
| [4] |
闫潇,邓毅,马骏, 等. 顺铂毒性损伤机制及中药防治机制的研究进展[J]. 中国实验方剂学杂志, 2021, 27(5): 233-242.
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
李卫霞,陈剑华,郭旭丽, 等. 氢水对高脂高糖饲料喂养大鼠主要脏器和肝损伤的调节作用[J]. 生命科学研究, 2021, 25(3): 202-208. DOI: 10.16605/j.cnki.1007-7847.2020.07.0211.
|
| [9] |
张昭,魏娅楠,仪杨, 等. 水相中氢气浓度检测方法的建立[J]. 生物技术进展, 2020, 10(2): 158-163.
|
| [10] |
朱珊珊,陈鑫,颜巧妍, 等. 抗肿瘤药物的临床应用进展[J]. 中国现代医生, 2019, 57(9): 164-168.
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
T/CAS 500-2021富氢包装饮用水[S].
|
| [17] |
|
| [18] |
|
| [19] |
周兴,李雪梅,李晓辉. 以线粒体为靶点治疗肝损伤的研究进展[J]. 重庆理工大学学报(自然科学版), 2021, 35(9): 184-193.
|
| [20] |
|
| [21] |
|
| [22] |
|
| [1] | LIU Rong, LI Guoxin, LI Yunze, LIANG Lizhe, LU Fei, DANG Shijing, WU Hongjiang, LIU Xiaoyi. Study on the Correlation and Diagnostic Value of Multiple Inflammatory and Oxidative Stress Indices in Lower Extremity Arteriosclerotic Obliteration [J]. Chinese General Practice, 2025, 28(18): 2234-2240. |
| [2] | LIU Qingfang, WEI Youshi, XIAO Fei, ZHOU Chunxiang, LIU Qun, YUAN Hui, CAO Tianran. Ergothionein Improves Cognitive Dysfunction in Vascular Dementia Rats by Activating NRF2/HO-1 Signaling Pathway [J]. Chinese General Practice, 2025, 28(17): 2156-2162. |
| [3] | ZHANG Ning, FAN Shiming, REN Ming, SHEN Youlu, MA Yanmei, DOU Xiaohong, PU Cuo, LU Xingqin, HUANG Qiang, XUE Rui, WANG Fuyan, LIN Ying, ZHANG Jihui, TIAN Huizhen, HAN Ping, HAN Yujuan, HAN Shuping, LIU Qingling, LU Tianlong, LU Yongliang, E Weijian. Study on the Relationship between Homocysteine Levels, Polymorphisms of Homocysteine Metabolizing Enzyme Genes, Blood Pressure, and Oxidative Stress Levels in Hypertensive Patients at Different Altitudes [J]. Chinese General Practice, 2025, 28(15): 1862-1870. |
| [4] | ZHU Jing, XIE Ji, HU Xiaoxia. Study on Anti-inflammatory and Anti-oxidative Stress Mechanism of Sitagliptin: a Dipeptidyl Peptidase-4 Inhibitor [J]. Chinese General Practice, 2025, 28(12): 1543-1548. |
| [5] | ZHANG Jiateng, KONG Ming, CHEN Yu, DUAN Zhongping. Study on the Efficacy and Safety of Kuhuang Injection and Kuhuang Granules in the Sequential Treatment of Drug-induced Liver Injury: a Non-inferiority Randomized Controlled Trial [J]. Chinese General Practice, 2024, 27(26): 3249-3254. |
| [6] | LIU Xinyi, LIU Zhandong. Research Progress of Anxiety and Depression Related to Chronic Fatigue Syndrome [J]. Chinese General Practice, 2023, 26(35): 4477-4482. |
| [7] | ZHAO Wei, TANG Rongjie, YANG Shanshan, YANG Fang, SUN Feng, LIAN Qiufang. The Role and Molecules Mechanism of Klotho in Renal Injury in Salt-sensitive Hypertension [J]. Chinese General Practice, 2023, 26(24): 3042-3049. |
| [8] | ZHU Li, XING Jiajia, WEI Juanfang, WANG Wenchun, ZHANG Anren. Research Advances in the Mechanism of Short-chain Fatty Acids in Neurodegenerative Diseases [J]. Chinese General Practice, 2023, 26(24): 3061-3066. |
| [9] | ZHAO Xiaolong, NIU Zhiping, TAN Jidong, HAN Donghui, YANG Fa, WEN Weihong, WANG Anhui, QIN Weijun. Association of Oxidative Stress and Energy Metabolism with Sperm Quality in Chinese Male Adults [J]. Chinese General Practice, 2023, 26(11): 1318-1324. |
| [10] | WANG Nan, Motuziuk OLEKSANDR, Mishchenko IRYNA, ZHOU Yingting. Levels of Relevant Inflammatory Factors and Oxidative Stress Markers in Alcoholic Myopathy: a Meta-analysis [J]. Chinese General Practice, 2022, 25(33): 4123-4129. |
| [11] | Shaokun WANG, Shiqiang WANG, Yijie WANG, Zhihan XU. Research Progress on the Effect of Exercise and Neurobiological Mechanism on Depression [J]. Chinese General Practice, 2022, 25(27): 3443-3451. |
| [12] | Zhimin DING, Kaiqi SU, Jing GAO, Tingyu CHEN, Yixuan FENG, Xiaodong FENG. Research Progress on the Relationship between Mitochondrial Dysfunction and Post-stroke Depression [J]. Chinese General Practice, 2022, 25(12): 1528-1532. |
| [13] | LYU Yanhang,WU Shanshan,WANG Zhenchang,YE Xuejin,FU Yanqing,DUAN Guijiao,SU Xiaowen,NONG Xiaoxin. Clinical,Serum Inflammatory Cytokine,Immune,and Oxidative Stress Responses to Rougan Huaxian Granules with Transplantation of Bone Mesenchymal Stem Cells in Decompensated Cirrhosis Patients [J]. Chinese General Practice, 2021, 24(3): 355-362. |
| [14] | FU Yang,XIA Ji,HAN Fengjuan. Effects of Active Components of Lichong Shengsuiyin on Regulating Genes of Ovarian Cancer Stem Cells and Cisplatin Resistance and Its Mechanism [J]. Chinese General Practice, 2019, 22(9): 1078-1083. |
| [15] | XI Yue,WANG Yuanyuan,CUI Xiuling. Protective Effects and Mechanism of α-lipoic Acid in Graves' Disease Complicated with Liver Damage [J]. Chinese General Practice, 2019, 22(8): 931-935. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||